Markets:

Overview

News

Currencies

International

Treasuries

Rocket Pharmaceuticals, Inc. - Common Stock (NQ:RCKT)

3.420 +0.080 (+2.40%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Rocket Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Rocket Pharmaceuticals to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference

September 30, 2021

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Rocket Pharmaceuticals Presents Clinical Data from RP-A501 Trial in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2021

September 14, 2021

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Rocket Pharmaceuticals Announces Upcoming Danon Disease Presentation at the Heart Failure Society of America Annual Scientific Meeting 2021

September 10, 2021

From Rocket Pharmaceuticals, Inc.

Via Business Wire

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Rocket Pharmaceuticals Appoints Isabel Carmona, J.D., as Chief Human Resources Officer

September 07, 2021

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Rocket Pharmaceuticals Announces $26.4 Million Private Placement

August 30, 2021

From Rocket Pharmaceuticals, Inc.

Via Business Wire

FDA Lifts Clinical Hold On Rocket Pharma's X-Linked Inherited Disorder Trial ↗

August 16, 2021

The

Via Benzinga

Rocket Pharmaceuticals Announces FDA Lifts Clinical Hold on Danon Disease Trial of RP-A501

August 16, 2021

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Rocket Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Progress

August 09, 2021

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Rocket Pharmaceuticals to Host Conference Call on Aug. 9 at 4:30 p.m. ET to Discuss Second Quarter Results and Recent Business Highlights

August 03, 2021

From Rocket Pharmaceuticals, Inc.

Via Business Wire

The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus ↗

June 27, 2021

Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (NYSE: LLY) stood out among big...

Via Benzinga

Earnings Scheduled For August 9, 2021 ↗

August 09, 2021

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...

Via Benzinga

74 Biggest Movers From Yesterday ↗

July 27, 2021

Gainers Bit Digital, Inc. (NASDAQ: BTBT) shares jumped 109.7% to close at $8.87 on Monday after the company announced it entered into a second strategic co-mining agreement with...

Via Benzinga

Short Interest Report: AMC Entertainment Shorts Sound Retreat ↗

May 15, 2021

This week, Bed Bath & Beyond short interest hit a three-month high and the AMC Entertainment short position was down sharply.

Via Talk Markets

Rocket Pharmaceuticals Announces Positive Data From RP-L102, RP-L201 Gene Therapy Programs ↗

May 13, 2021

Rocket Pharmaceuticals Inc (NASDAQ: RCKT) has announced positive data from its Fanconi Anemia (FA), Leukocyte Adhesion Deficiency-I (LAD-I), and Pyruvate...

Via Benzinga

Rocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia, Leukocyte Adhesion Deficiency-I, and Pyruvate Kinase Deficiency Programs at 24th Annual Meeting of the American Society of Gene and Cell Therapy

May 13, 2021

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Rocket Pharma Stock Drops After FDA Institutes Clinical Hold On RP-A501 Danon Disease Trial ↗

May 11, 2021

Tucked in the Q1 earnings release, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) has paused the RP-A501 Phase 1 trial to treat Danon Disease to address the FDA...

Via Benzinga

45 Stocks Moving In Tuesday's Mid-Day Session ↗

May 11, 2021

Gainers Sequential Brands Group, Inc. (NASDAQ: SQBG) surged 52.6% to $14.76 after dropping 11% on Monday. 3D Systems Corporation (NYSE: DDD) shares climbed 22.9% to $21.83 after...

Via Benzinga

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 11, 2021

Gainers Cerecor (NASDAQ:CERC) shares rose 14.56% to $2.91 during Tuesday's pre-market session. The company's market cap stands at $281.4 million. Larimar...

Via Benzinga

30 Stocks Moving in Tuesday's Pre-Market Session ↗

May 11, 2021

Gainers China Xiangtai Food Co., Ltd. (NASDAQ: PLIN) shares rose 21.3% to $0.91 in pre-market trading. Intec Pharma Ltd (NASDAQ: NTEC) rose 17.8% to $4.90 in pre-market trading...

Via Benzinga

10 Stocks Moving In Monday's After-Hours Session ↗

May 10, 2021

Gainers NortonLifeLock (NASDAQ: NLOK) shares are trading higher after the company reported better-than-expected Q4 sales results and issued FY22 EPS and sales guidance above...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗

May 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 10, 2021

Gainers Vir Biotechnology (NASDAQ:VIR) sha...

Via Benzinga

Rocket Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent Progress

May 10, 2021

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Expected Moves: Draftkings, Square, Roku, AMC, Peloton, Moderna, Rocket, Uber, Cronos And More ↗

May 03, 2021

The Broader Markets Last Week – SPY closed slightly higher on the week but below its intra-week highs. The VIX closed higher on the week, up to 18.60 from 17. This...

Via Benzinga

Topics Stocks

Rocket Pharmaceuticals Announces Upcoming Clinical Data Presentations at the 24th Annual Meeting of the American Society of Gene and Cell Therapy

April 27, 2021

From Rocket Pharmaceuticals, Inc.

Via Business Wire

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

Rocket Pharmaceuticals Reports Positive Long-Term Clinical Data from RP-L201 Trial for the Treatment of Leukocyte Adhesion Deficiency-I at the Clinical Immunology Society 2021 Annual Meeting

April 14, 2021

From Rocket Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.